JD Supra Corporate Brief: Stopping 23andMe Sales, Buying Privacy Liabilities, Changing Proxy Policies, Approving REIT Conversions

On November 27, 1924, the very first Macy’s Thanksgiving Day parade was held. As it should be… Happy Holidays!

The FDA is routinely criticized in cases where regulation is perceived to stymy innovation. Shutting down 23andMe isn’t one of them… (Andrew Ittleman and Kelly Lightfoot, JD Supra Perspectives)

Every mobile app that glitters is not gold – sometimes it’s a hotbed of potential liability for privacy law violations… (MoFo Tech)

Here’s an in-depth look at what banks and trust companies need to know about the SEC’s new municipal advisor rules… (Goodwin Procter)

Institutional Shareholder Services is changing its benchmark proxy voting policies beginning next year… (Robert Wayne Dockery and Nancy Sarmiento at Akin Gump)

IRS rules on real estate investment trust conversions – do you have the REIT stuff? (Corporate Law Report)

A cautionary tale for medical device manufacturers: when employees provide advice outside the approved label, the manufacturer may face liability… (Soo Kim at Sedgwick)

Could a captive insurance market provide your company with an alternative to traditional risk management approaches? (Peter Felsenfeld and David McMahon at Barger & Wolen)

The federal government invests significant resources to combat health care fraud and abuse. Here’s what they’ll be doing over the next five years… (Bruce Armon and Karilynn Bayus at Saul Ewing)

Coming to America? Here’s a comprehensive overview of the US franchise market aimed at foreign franchisors… (Susan Grueneberg at Snell & Wilmer)

Get more law news at JD Supra>>